کد مقاله | کد نشریه | سال انتشار | مقاله انگلیسی | نسخه تمام متن |
---|---|---|---|---|
4326499 | 1614084 | 2010 | 6 صفحه PDF | دانلود رایگان |
![عکس صفحه اول مقاله: Synergistic protective effects of humanin and necrostatin-1 on hypoxia and ischemia/reperfusion injury Synergistic protective effects of humanin and necrostatin-1 on hypoxia and ischemia/reperfusion injury](/preview/png/4326499.png)
Since several different pathways are involved in cerebral ischemia/reperfusion injury, combination therapy rather than monotherapy may be required for efficient neuroprotection. In this study, we examined the protective effects of an apoptosis inhibitor Gly14-humanin (HNG) and a necroptosis inhibitor necrostatin-1 (Nec-1) on hypoxia/ischemia/reperfusion injury. Cultured mouse primary cortical neurons were incubated with Nec-1, HNG or both in a hypoxia chamber for 60 min. Cell viability was determined by MTS assay at 24 h after oxygen-glucose deprivation (OGD) treatment. Mice underwent middle cerebral artery occlusion for 75 min followed by 24 h reperfusion. Mice were administered HNG and/or Nec-1 (i.c.v.) at 4 h after reperfusion. Neurological deficits were evaluated and the cerebral infarct volume was determined by TTC staining. Nec-1 or HNG alone had protective effects on OGD-induced cell death. Combined treatment with Nec-1 and HNG resulted in more neuroprotection than Nec-1 or HNG alone. Treatment with HNG or Nec-1 reduced cerebral infarct volume from 59.3 ± 2.6% to 47.0 ± 2.3% and 47.1 ± 1.5%, respectively. Combined treatment with HNG and Nec-1 improved neurological scores and decreased infarct volume to 38.6 ± 1.5%. In summary, we demonstrated that the combination treatment of HNG and Nec-1 conferred synergistic neuroprotection on hypoxia/ischemia/reperfusion injury in vitro and in vivo. These findings provide a novel therapeutic strategy for the treatment of stroke by combining anti-apoptosis and anti-necroptosis therapy.
Research highlights
► Cerebral ischemia/reperfusion induces different kinds of cell death, including necrosis, necroptosis, and apoptosis.
► We designed a cocktail of an apoptosis inhibitor (HNG) and a necroptosis inhibitor (Nec-1) that simultaneously acts on distinct cell death pathways in vitro and in vivo.
► Administration of this cocktail protected against cerebral ischemia/reperfusion injury. Our findings suggest that this cocktail could represent a promising new therapeutic strategy for stroke.
Journal: Brain Research - Volume 1355, 8 October 2010, Pages 189–194